Inthe article, there are various benefits of psilocybin highlighted bythe researchers. They claim that, since concerns like methods of paincontrol and chemotherapies among cancer patients have been dealt withappropriately, it was time to address issues like existentialsufferings and end-life distress. As a result, scientists haveproposed the use of psilocybin as a means of addressing thistreatment gap. They favor the drug in dealing with clinicalconditions, for instance, post-traumatic stress and addiction, amongother things mentioned above.
Itis asserted that a single session of the drug can make someone havemeaningful spiritual experiences. Feelings of anxiety surroundingdeath which are present during the treatment period are eliminated.Weir provides that the proponents of the method emphasize that underappropriate conditions and usage, the substance may address suchthings as behaviors and attitudes in patients to ensure positiveoutcomes (1). Similarly, it handles the profound and abrupt moodshifting of an individual adding that it increases the well-being ofa person as well as life satisfaction. They praise the drug claimingthat it is arguably above any medication in psychiatry since thepatients realized the quality of their life upon consuming the drug.
Someof the drawbacks associated with the medicine are that it leads todecreased activity as well as connectivity in brain`s hub region. Itcan exacerbate mental complications or push underlying braindisorders into expression. Another drawback about the drug is that itcan cause attention disruption. It may also cause problems to peoplewho experiences lightheadedness or loss of consciousness. Accordingto Weir, other worrying adverse effects are psychological distressand even psychosis (2). The drug becomes less effective as a personcontinue using it.
Inmy opinion, the drug is appropriate for cancer patients because ithelps them move beyond the distress that develops after diagnosis.From the volunteers mentioned in the article, it is appropriate sinceit produced a mystical-type experience that had some significantpersonal meaning later in life. It ensures a favorable behavior andattitude on the patient which could be good news for the family andfriends of the patients. It is ideal for addressing distress andanxiety concerns. Weir states that, if these issues are not dealtwith promptly, may complicate the treatment process and can alsoincrease suicidal thinking among the patients because most of themmay not see the essence of life (3). Altruism is also increased as aresult of the drug.
Mystance is that the experiences tend to open up the patients to asense of existential wonder, fears begin to dissolve, and the patientcan perceive a meaningful life. Those benefits last for many monthsin a patient hence encouraging outcome of the drug Weir (3). The drugis also effective since it does not remain in the body thus avoidingneurochemical effects and no adverse effects as a result.
Thedrug has been used in illuminating the functioning of the humanbrain. The approach has assisted in addressing depression and drugaddiction issues. Psilocybin can reduce alcohol misuse and thefeeling of despair in that it creates a mystical experience. Weirstates that, though the drug has not yet been proved scientificallyhow it functions in the brain by researchers, it is claimed that thepsychedelic experience generated by the drug is the one responsiblefor the positive effects (4). It helps people change their attitudeand perspective towards behaviors like addictions. The behaviors arepositively changed as a result, and the depression is eliminated.
Weir,Kirsten. “One-hit Wonder: Couldthe Psychedelic Drug Psilocybin help ease the Existential DistressCommon in People with Cancer?” Journalof Psychopharmacology 46.11(2015): 1-4